Oramed Pharmaceuticals (ORMP) Operating Margin (2016 - 2025)
Oramed Pharmaceuticals' (ORMP) quarterly Operating Margin came in at 225.0% in Q1 2025, up 60.0% on a QoQ basis from 562.46% in Q2 2023.
Oramed Pharmaceuticals (ORMP) Operating Margin (2016 - 2025) Analysis & Trends
Oramed Pharmaceuticals (ORMP) has 8 years of Operating Margin data on file, last reported at 225.0% in Q1 2025.
- Quarterly Operating Margin changed N/A year-over-year to 225.0% in Q1 2025, while the trailing twelve-month figure through Dec 2025 was 754.4% (changed N/A YoY) and the FY2025 annual result came in at 754.4%, changed N/A from the prior year.
- Operating Margin climbed to 225.0% in Q1 2025, from 562.46% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 225.0% in Q1 2025 to a low of 1693.92% in Q2 2022.
- A 4-year average of 1051.65% and a median of 1048.44% in 2021 frame the typical range for Operating Margin.
- The widest YoY moves for Operating Margin: up 113145 bps in 2023, down 90751 bps in 2023.
- Tracing ORMP's Operating Margin over 4 years: stood at 896.15% in 2021, then slumped by 52 bps to 1363.5% in 2022, then soared by 59 bps to 562.46% in 2023, then soared by 60 bps to 225.0% in 2025.
- The last three Operating Margin figures came in at 225.0% (Q1 2025), 562.46% (Q2 2023), and 781.98% (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 17.93% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.36% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.75% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -35.57% |
| 10 | Oramed Pharmaceuticals | 196.17 Mn | 196.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -225.00% |
| Jun 30, 2023 | -562.46% |
| Mar 31, 2023 | -781.98% |
| Dec 31, 2022 | -1,363.50% |
| Sep 30, 2022 | -1,200.73% |
| Jun 30, 2022 | -1,693.92% |
| Mar 31, 2022 | -1,689.49% |
| Aug 31, 2021 | -896.15% |
| Nov 30, 2019 | -360.39% |
| Aug 31, 2019 | -344.35% |
| May 31, 2019 | -597.95% |
| Feb 28, 2019 | -535.74% |
| Nov 30, 2018 | -688.43% |
| Aug 31, 2018 | -510.53% |
| May 31, 2018 | -734.85% |
| Feb 28, 2018 | -515.07% |
| Nov 30, 2017 | -447.14% |
| Aug 31, 2017 | -461.65% |
| May 31, 2017 | -349.27% |
| Feb 28, 2017 | -550.74% |